# US 2021/0369156 A1 · Wake-up batteries for invasive biosensors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0369156 A1
- Document ID: US20210369156A1
- Status: Published application
- Kind: A1
- Application number: 17/332,048
- Filed: 2021-05-27
- Published: 2021-12-02
- Earliest claimed: 2016-08-09
- Assignees: Verily Life Sciences LLC
- Applicants: Verily Life Sciences LLC
- Inventors: William Biederman; Zenghe Liu
- Web page: https://patentgrep.com/patent/US20210369156A1

## CPC

- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/0024: {for multiple sensor units attached to the patient, e.g. using a body or personal area network}
- A61B 5/1451: {for interstitial fluid}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 90/98: using electromagnetic means, e.g. transponders
- G01N 27/3277: {being a redox reaction, e.g. detection by cyclic voltammetry (voltammetry per se G01N27/42, G01N27/48)}
- H01M 4/02: Electrodes composed of, or comprising, active material
- H01M 6/32: activated through external addition of electrolyte or of electrolyte components
- H01M 6/34: Immersion cells, e.g. sea-water cells
- H01M 6/385: {by insertion of electrodes}
- H01M 8/083: Alkaline fuel cells
- H01M 8/141: {the anode and the cathode being gas-permeable electrodes or electrode layers}
- H01M 16/00: Structural combinations of different types of electrochemical generators
- A61B 2560/0209: adapted for power saving
- A61B 2560/0214: of power generation or supply
- H01M 2010/4292: {Aspects relating to capacity ratio of electrodes/electrolyte or anode/cathode}
- Y02E 60/50: Fuel cells
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01M: PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

Example biosensor devices having wake-up batteries and associated methods are disclosed. One example device includes a biosensor that has a first electrode for insertion into a subcutaneous layer beneath a patient's skin, and a second electrode coupled to the first electrode for insertion into the subcutaneous layer, and a first battery to apply a voltage across the first and second electrodes, the first battery at least partially electrically decoupled from the electrodes. The device also includes a second battery having an anode material coupled to the first electrode for insertion into the subcutaneous layer, and a portion of the second electrode. The second battery is activatable upon immersion in an electrolytic fluid. The device also includes a wake-up circuit to receive a signal from the second battery and, in response, to electrically couple the first battery to the first and second electrodes to activate the biosensor.

## Claims

### Claim 1

A device comprising:
a biosensor comprising:
a first electrode having a distal end for insertion into a subcutaneous layer beneath a patient's skin,
a second electrode coupled to the first electrode, a portion of the second electrode for insertion into the subcutaneous layer, and
a first battery to apply a voltage across the first and second electrodes, the first battery at least partially electrically decoupled from the electrodes;
a second battery comprising:
an anode material coupled to a portion of the distal end of the first electrode, the anode material for insertion into the subcutaneous layer, and
a portion of the second electrode,
the second battery activatable upon immersion in an electrolytic fluid; and
a wake-up circuit coupled to the second battery to receive a signal from the second battery and, in response, to electrically couple the first battery to the first and second electrodes.

### Claim 2 (depends on 1)

The device of claim 1, further comprising a glucose oxidase material disposed on a portion of the distal end of the first electrode.

### Claim 3 (depends on 1)

The device of claim 1, further comprising a radio frequency (“RF”) transmitter, and wherein:
the first battery is at least partially electrically decoupled from the RF transmitter and is further to apply power to the RF transmitter, and
the wake-up is further to electrically couple the first battery to the RF transmitter in response to receiving the signal from the second battery.

### Claim 4 (depends on 1)

The device of claim 1, wherein:
the first electrode comprises a platinum material;
the second electrode comprises a silver/silver-chloride material coating a portion of the first electrode; and
the anode material comprises zinc, iron, aluminum, or nickel.

### Claim 5 (depends on 1)

The device of claim 1, wherein the anode material comprises approximately 10 to 100 nanograms (“ng”) of zinc, approximately 10 to 100 ng of nickel, approximately 10 to 100 ng of iron, or approximately 3 to 30 ng of aluminum.

### Claim 6 (depends on 1)

The device of claim 1, wherein the wake-up circuit comprises one or more of (1) a voltage threshold detection circuit and a reference voltage source, (2) a current threshold detection circuit and a reference current source, (3) a ring oscillator, (4) a power-on reset circuit, or (5) an NMOS footer switch.

### Claim 7 (depends on 1)

The device of claim 1, wherein the biosensor further comprises a processor, and wherein the wake-up circuit is further to electrically couple the first battery to the processor.

### Claim 8 (depends on 8)

The device of claim 8, wherein the wake-up circuit comprises a ring oscillator electrically coupled to a clock circuit of the processor to activate the clock circuit after receiving the signal from the second battery.

### Claim 9

A method comprising:
providing first and second electrodes, the first electrode having a distal end for insertion into a subcutaneous layer beneath a patient's skin, the second electrode coupled to the first electrode, a portion of the second electrode for insertion into the subcutaneous layer;
applying an anode material proximate to the distal end of the first electrode;
coupling a wake-up circuit to the first and second electrodes to receive a signal from a second battery in response to immersion of the second battery in an electrolytic fluid, the second battery comprising the anode material and the second electrode; and
coupling a first battery to the wake-up circuit, the wake-up circuit to electrically couple the first battery to the first and second electrodes in response to the signal from the second battery.

### Claim 10 (depends on 9)

The method of claim 9, further comprising a glucose oxidase material disposed on a portion of the distal end of the first electrode.

### Claim 11 (depends on 9)

The method of claim 9, further comprising coupling a radio frequency (“RF”) transmitter to the wake-up circuit, and wherein:
the first battery is at least partially electrically decoupled from the RF transmitter and is further to apply power to the RF transmitter, and
the wake-up is further to electrically couple the first battery to the RF transmitter in response to receiving the signal from the second battery.

### Claim 12 (depends on 9)

The method of claim 9, wherein:
the first electrode comprises a platinum material;
the second electrode comprises a silver/silver-chloride material coating a portion of the first electrode; and
the anode material comprises zinc, iron, aluminum, or nickel.

### Claim 13 (depends on 9)

The method of claim 9, wherein the anode material comprises approximately 10 to 100 nanograms (“ng”) of zinc, approximately 10 to 100 ng of nickel, approximately 10 to 100 ng of iron, or approximately 3 to 30 ng of aluminum.

### Claim 14

A method comprising:
inserting an insertable portion of a biosensor and a second battery into a patient's skin and into the patient's interstitial fluid, the insertable portion comprising:
a distal end of a first electrode and a portion of second electrode, the first electrode coupled to the second electrode,
the biosensor further comprising a first battery to apply a voltage across the first and second electrodes, the first battery at least partially electrically decoupled from the electrodes,
the second battery comprising an anode material coupled to a portion of the distal end of the first electrode and a portion of the second electrode;
generating a signal by the second battery after the second battery is immersed in the patient's interstitial fluid;
electrically coupling the first battery to the first and second electrodes by a wake-up circuit in response to receiving the signal from the second battery; and
providing sensor information from the biosensor to a radio frequency (“RF”) transmitter.

### Claim 15 (depends on 14)

The method of claim 14, further comprising transmitting the sensor information to a remote wireless device.

### Claim 16 (depends on 15)

The method of claim 15, wherein the transmitting is performed using a radio frequency identification (“RFD”) or near-field communication (“NFC”) technique.

### Claim 17 (depends on 14)

The method of claim 14, wherein the biosensor comprising a processor, and further comprising activating a clock circuit of the processor by the wake-up circuit.

### Claim 18

A device comprising:
a biosensor comprising:
a first electrode having a distal end for insertion into a subcutaneous layer beneath a patient's skin, and
a second electrode coupled to the first electrode, a portion of the second electrode for insertion into the subcutaneous layer, and
a first battery comprising:
an anode material coupled to a portion of the distal end of the first electrode, the anode material for insertion into the subcutaneous layer, and
a portion of the second electrode,
the first battery activatable upon immersion in an electrolytic fluid to apply a voltage to the first and second electrodes.

### Claim 19 (depends on 18)

The device of claim 18, further comprising a glucose oxidase material disposed on a portion of the distal end of the first electrode.

### Claim 20 (depends on 18)

The device of claim 18, further comprising a radio frequency (“RF”) transmitter, and wherein the first battery is further to apply power to the RF transmitter.
